Prof. Alex Mullen


Prof Alex Mullen

Prof. Alex Mullen

Chief Scientific Officer, Bio-Images Drug Delivery Ltd

Contact details

Telephone +44 (0)141 552 8791


Professor Alex Mullen is a Professor at the University of Strathclyde and a registered pharmacist with commercial R&D experience, specialising in oral dosage formulation development.

Professor Mullen has an extensive research portfolio, encompassing oral and vesicular drug delivery technologies, controlled release, drug eluting stents, liposomes and vaginal drug delivery. Professor Mullen provides scientific direction as Chief Scientist for drug delivery and formulation.  He is one of the inventors of OralogiK™.

About Bio-Images Drug Delivery Ltd

BDD aims to be the number one integrated pharmaceutical Development centre. Because we recognise that one size does not fit all we specialise in providing responsive, flexible and innovative solutions to our customers.

Our success is built upon solid scientific ability, strengthened by shared values across the Company. Our commitment to our customers is at the forefront of everything we do; we always keep our promise and deliver when we say we will. We are a company of integrity and value and we take pride in everything that we do.

Presentation title:

OrlogiK: New advances in chronotheraputics


The development of controlled release formulations has brought many clinical and economic benefits. BDD has developed oral drug delivery preparations that provide a range of drug release profiles that can be developed for single or multiple drug delivery. The profiles can combine separate ‘pulse’ releases or an initial release combined with delayed sustained release. Their behaviour in man has been demonstrated by the use of the nuclear imaging technique: gamma scintigraphy. Potential applications in sleep maintenance, pain management and cardiovascular disease have been demonstrated in this way, although the formulations are not limited to these therapeutic areas; indeed, they could be applied to a broad range of drugs and disease groups.

Please click to logos to go back to the agenda

NRN workshop logos

Back to top

Gwenin - Applied Research in Chemistry and Public Health (ARCH)

School of Chemistry, Bangor University, Bangor, Gwynedd, LL57 2UW, UK

Direct Line: 0044 1248 383741   email:

Gwenin - Applied Research in Chemistry and Public Health (ARCH)


News: February 2020

Swansea University announces CALIN 11Picture1€5 million of additional funding announced for Ireland-Wales innovation project that is driving life science sector growth across the two countries.

News: December 2019

jos.jpgCongratulations to Josh for passing his MRes

News: December 2019

towerDr. Gwenin leaves Bangor

News: November 2019

P1000779Congratulations to Pat on passing his PhD